Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NETWORK × GastroEsophageal Cancer × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Astrocytoma 29 Central Nervous System Neoplasms 28 Unspecified Adult Solid Tumor, Protocol Specific 18 Ovarian Neoplasms 17 Oligodendroglioma 17 Medulloblastoma 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lung Neoplasms 15 Optic Nerve Glioma 14 Neuroblastoma 14 Lymphoma 14 Carcinoma, Non-Small-Cell Lung 14 Leukemia 13 Glioblastoma 13 Familial ependymoma 12 Choroid Plexus Neoplasms 12 Carcinoma, Ovarian Epithelial 12 Fallopian Tube Neoplasms 11 Burkitt Lymphoma 11 Breast Neoplasms 11 Sarcoma 10 Colorectal Neoplasms 9 Brain Neoplasms 9 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 8 Brenner Tumor 8 Lymphoma, Non-Hodgkin 7 Glioma 7 Colonic Neoplasms 7 Uterine Cervical Neoplasms 6

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡